1791 related articles for article (PubMed ID: 36413)
1. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
2. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
3. Effects of metyrapone and a combined alpha- and beta-adrenergic blockade on plasma glucose recovery from insulin-induced hypoglycaemia in pigs.
Gürtler H
Exp Clin Endocrinol; 1986 Aug; 87(3):337-40. PubMed ID: 3536538
[TBL] [Abstract][Full Text] [Related]
4. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
6. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
[TBL] [Abstract][Full Text] [Related]
8. No effect of beta-adrenergic blockade on hypoglycaemic effect of glucagon-like peptide-1 (GLP-1) in normal subjects.
Toft-Nielsen M; Hvidberg A; Hilsted J; Dige-Petersen H; Holst JJ
Diabet Med; 1996 Jun; 13(6):544-8. PubMed ID: 8799658
[TBL] [Abstract][Full Text] [Related]
9. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.
Garber AJ; Cryer PE; Santiago JV; Haymond MW; Pagliara AS; Kipnis DM
J Clin Invest; 1976 Jul; 58(1):7-15. PubMed ID: 6491
[TBL] [Abstract][Full Text] [Related]
10. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.
Walter RM; Dudl RJ; Palmer JP; Ensinck JW
J Clin Invest; 1974 Nov; 54(5):1214-20. PubMed ID: 4153713
[TBL] [Abstract][Full Text] [Related]
11. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
12. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
13. Pre-exposure to glucagon impairs glucose recovery after insulin-induced hypoglycemia in man.
Clausen N; Adamson U; Lins PE
Horm Metab Res; 1987 Aug; 19(8):375-8. PubMed ID: 2889657
[TBL] [Abstract][Full Text] [Related]
14. Epinephrine-induced insulin resistance in man.
Deibert DC; DeFronzo RA
J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
[TBL] [Abstract][Full Text] [Related]
15. Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids.
Avogaro A; Beltramello P; Gnudi L; Maran A; Valerio A; Miola M; Marin N; Crepaldi C; Confortin L; Costa F
Diabetes; 1993 Nov; 42(11):1626-34. PubMed ID: 8405705
[TBL] [Abstract][Full Text] [Related]
16. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
Boyle PJ; Shah SD; Cryer PE
Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
[TBL] [Abstract][Full Text] [Related]
18. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
[TBL] [Abstract][Full Text] [Related]
19. Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man.
Rosen SG; Clutter WE; Berk MA; Shah SD; Cryer PE
J Clin Invest; 1984 Feb; 73(2):405-11. PubMed ID: 6142057
[TBL] [Abstract][Full Text] [Related]
20. The adrenergic contribution to glucose counterregulation in type I diabetes mellitus. Dependency on A-cell function and mediation through beta 2-adrenergic receptors.
De Feo P; Bolli G; Perriello G; De Cosmo S; Compagnucci P; Angeletti G; Santeusanio F; Gerich JE; Motolese M; Brunetti P
Diabetes; 1983 Oct; 32(10):887-93. PubMed ID: 6311652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
